Transthyretin (TTR) for Neurodegenerative Disease Research
StressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid
Read moreStressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid
Read moreStressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic
Read moreTau is a key protein implicated in neurodegenerative diseases, such as Alzheimer’s and dementia. Tau Pre-formed Fibrils (PFFs) for Modelling
Read moreSonification: What, Why, How and Best Practices A StressMarq Biosciences .pdf White Paper Neurodegenerative Disease Research As populations age, the
Read moreNeuroscience is an interdisciplinary science devoted to the study of the nervous system’s structure and function. A StressMarq Biosciences .pdf
Read moreCoya Therapeutics’ investigational low-dose interleukin-2 (IL-2) for subcutaneous administration, COYA 301, has been found to increase Treg function and halt
Read moreNew Phase 3 Data has shown a positive correlation between the human monoclonal antibody ADUHELM™ treatment effect on biomarkers and
Read moreGenentech’s investigational antibody for the treatment of early-stage Alzheimer’s disease, Gantenerumab, has been granted Breakthrough Therapy Designation by the U.S.
Read moreEli Lilly & Co and Prevail Therapeutics announced a definitive agreement for Lilly to acquire Prevail for a total consideration
Read more